Status:
COMPLETED
Pulmonary Fibrosis and Telomerase Mutation Study
Lead Sponsor:
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Collaborating Sponsors:
Bichat Hospital
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
This study is an observational and retrospective study of patients with pulmonary fibrosis associated or not with telomerase mutation. The purpose of this study is to describe in detail the cases wit...
Detailed Description
Two "control" subjects will be enrolled for one subject with telomerase mutation. The data are all the results of investigations conducted for the diagnosis of idiopathic pulmonary fibrosis and durin...
Eligibility Criteria
Inclusion
- Diffuse interstitial lung disease on CT scan
- Telomerase mutation analysis
Exclusion
- Presence of connective tissue disease, or pneumoconiosis or drug induced lung disease
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT01501578
Start Date
December 1 2011
End Date
December 1 2015
Last Update
February 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louis Pradel Hospital (Bâtiment A4)
Lyon, France, 69677